Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB–III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensitivity-Reference-Cited by-同舟云学术

Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB–III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensitivity

Published:2016-03 Issue: Volume:55 Page:111-121
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Eggermont Alexander M.M.,Suciu Stefan,Rutkowski Piotr,Kruit Willem H.,Punt Cornelis J.,Dummer Reinhard,Salès François,Keilholz Ulrich,de Schaetzen Gaetan,Testori Alessandro

Funder

Fonds Cancer

Schering Plough Research International

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference24 articles.

1. Cutaneous melanoma;Eggermont;Lancet,2014

2. Final version of 2009 AJCC melanoma staging and classification;Balch;J Clin Oncol,2009

3. Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases;Balch;J Clin Oncol,2010

4. Site and timing of first relapse in stage III melanoma patients: implications for follow-up guidelines;Romano;J Clin Oncol,2010

5. Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes;Van Akkooi;Ann Surg,2008

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant immunotherapy for melanoma patients: progress and opportunities;ESMO Open;2024-05

2. Systemic Therapy for Melanoma: ASCO Guideline Update;Journal of Clinical Oncology;2023-10-20

3. Enhancing Skin Cancer Immunotheranostics and Precision Medicine through Functionalized Nanomodulators and Nanosensors: Recent Development and Prospects;International Journal of Molecular Sciences;2023-02-09

4. Comparison of efficacy and tolerability of adjuvant therapy for resected high-risk stage III-IV cutaneous melanoma: a systemic review and Bayesian network meta-analysis;Therapeutic Advances in Medical Oncology;2023-01

5. Cytokines, Interferons, and Hematopoietic Growth Factors;Holland‐Frei Cancer Medicine;2022-10-21